Smisson-Cartledge Biomedical
Smisson-Cartledge Biomedical: Innovating therapeutic solutions with portable infusion systems since 1996.
Founded
1996Smisson-Cartledge Biomedical: Innovating therapeutic solutions with portable infusion systems since 1996.
Founded in 1996, Smisson-Cartledge Biomedical is a medical device company dedicated to developing therapeutic solutions for thermal infusion care. Their core mission is to enhance patient outcomes through innovative medical technologies. The company's flagship product, the ThermaCor 1200 infusion system, is a portable device designed for various medical procedures, including hypothermia treatment, resuscitation, cardiac and transplant surgeries, and cancer treatment. Smisson-Cartledge Biomedical primarily focuses on the healthcare market, providing critical care solutions to hospitals and medical professionals.
Notable affiliated individuals include the founders, Dr. Fred Smisson and Dr. Robert Cartledge, who are key figures in the medical field. The company has attracted significant interest from investors in the healthcare sector due to its innovative approach and impactful products. Key achievements include the widespread adoption of the ThermaCor 1200 in critical care settings and recognition for improving patient care standards. Overall, Smisson-Cartledge Biomedical has made a substantial impact on the medical device industry by offering life-saving technologies that address critical clinical needs.
Companies similar to Smisson-Cartledge Biomedical include ThermalTherapeutic Systems, Thermedical, Cryothermic Systems and Zenith Technical Innovations.
Smisson-Cartledge Biomedical was founded in 1996.
Smisson-Cartledge Biomedical's headquarters is located in Macon, GA, US.
Smisson-Cartledge Biomedical's most recent funding round was for $2M (USD) in July 2012.
As of Jul 27, 2012, Smisson-Cartledge Biomedical has raised a total of $3.4M (USD).
Smisson-Cartledge Biomedical has 20 employees as of Feb 5, 2024.
Cryothermic Systems
